Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging

Archives of General Psychiatry

Volumn 70, Issue 1, 2013, Pages 87-97

  Doehrmann, Oliver ^a,b,d   Ghosh, Satrajit S ^a   Polli, Frida E ^a   Reynolds, Gretchen O ^a   Horn, Franziska ^a   Keshavan, Anisha ^a   Triantafyllou, Christina ^a,c   Saygin, Zeynep M ^a   Whitfield Gabrieli, Susan ^b   Hofmann, Stefan G ^d   Pollack, Mark ^e   Gabrieli, John D ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON UNIVERSITY   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DSM-IV; ELECTROENCEPHALOGRAM; EMOTION; FACIAL EXPRESSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LIEBOWITZ SOCIAL ANXIETY SCALE; MALE; SOCIAL PHOBIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL CORTEX; CLINICAL ASSESSMENT; PREDICTION; ADULT; ANXIETY DISORDER; BRAIN; GROUP THERAPY; INSTRUMENTATION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHOBIA; PREDICTIVE VALUE;

BIOLOGICAL MARKER;

ADULT; ANXIETY DISORDERS; BIOLOGICAL MARKERS; BRAIN; COGNITIVE THERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHOBIC DISORDERS; PREDICTIVE VALUE OF TESTS; PSYCHOTHERAPY, GROUP; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84871948952     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/2013.jamapsychiatry.5     Document Type: Article

References (63)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication [published correction appears in Arch Gen Psychiatry. 2005;62(7):768]. Arch Gen Psychiatry. 2005;62(6):593-602. (Pubitemid 40973434)
2. Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson JR, Schneier FR, Stein MB, Helstad CP. Impact of generalized social anxiety disorder in managed care. Am J Psychiatry. 2001;158(12):1999-2007. (Pubitemid 33104105)
3. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry. 1996;53(2):159-168. (Pubitemid 26049391)
4. Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry. 2000;157(10):1606-1613.
5. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry. 1992;49(4):282-288.
6. Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry. 1998;55(12):1133-1141. (Pubitemid 28558287)
7. Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry. 2004;61(10):1005-1013. (Pubitemid 39336534)
8. Blanco C, Heimberg RG, Schneier FR, Fresco DM, Chen H, Turk CL, Vermes D, Erwin BA, Schmidt AB, Juster HR, Campeas R, Liebowitz MR. A placebocontrolled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder. Arch Gen Psychiatry. 2010;67(3):286-295.
9. Hyman SE. The diagnosis of mental disorders: the problem of reification. Annu Rev Clin Psychol. 2010;6:155-179.
10. Koutsouleris N, Meisenzahl EM, Davatzikos C, Bottlender R, Frodl T, Scheuerecker J, Schmitt G, Zetzsche T, Decker P, Reiser M, Möller HJ, Gaser C. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry . 2009;66(7):700-712.
11. Kumari V, Peters ER, Fannon D, Antonova E, Premkumar P, Anilkumar AP, Williams SC, Kuipers E. Dorsolateral prefrontal cortex activity predicts responsiveness to cognitive-behavioral therapy in schizophrenia. Biol Psychiatry. 2009;66(6):594-602.
12. Canli T, Cooney RE, Goldin P, Shah M, Sivers H, Thomason ME, Whitfield- Gabrieli S, Gabrieli JD, Gotlib IH. Amygdala reactivity to emotional faces predicts improvement in major depression. Neuroreport. 2005;16(12):1267-1270. (Pubitemid 41225193)
13. Fu CH, Williams SC, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND, Donaldson C, Suckling J, Andrew C, Steiner H, Murray RM. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry. 2008;64(6):505-512.
14. Chen CH, Ridler K, Suckling J, Williams S, Fu CH, Merlo-Pich E, Bullmore E. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry. 2007;62(5):407-414. (Pubitemid 47284016)
15. Siegle GJ, Carter CS, Thase ME. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry. 2006;163(4):735-738. (Pubitemid 44464587)
16. Paulus MP, Tapert SF, Schuckit MA. Neural activation patterns of methamphet-amine- dependent subjects during decision making predict relapse. Arch Gen Psychiatry. 2005;62(7):761-768. (Pubitemid 41002757)
17. Molfese VJ, Molfese DL, Modgline AA. Newborn and preschool predictors of second-grade reading scores: an evaluation of categorical and continuous scores. J Learn Disabil. 2001;34(6):545-554.
18. Maurer U, Bucher K, Brem S, Benz R, Kranz F, Schulz E, van der Mark S, Steinhausen HC, Brandeis D. Neurophysiology in preschool improves behavioral prediction of reading ability throughout primary school. Biol Psychiatry. 2009;66(4):341-348.
19. Hoeft F, McCandliss BD, Black JM, Gantman A, Zakerani N, Hulme C, Lyytinen H, Whitfield-Gabrieli S, Glover GH, Reiss AL, Gabrieli JD. Neural systems predicting long-term outcome in dyslexia. Proc Natl Acad Sci U S A. 2011;108(1):361-366.
20. Nitschke JB, Sarinopoulos I, Oathes DJ, Johnstone T, Whalen PJ, Davidson RJ, Kalin NH. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry. 2009;166(3):302-310.
21. Whalen PJ, Johnstone T, Somerville LH, Nitschke JB, Polis S, Alexander AL, Davidson RJ, Kalin NH. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry. 2008;63(9):858-863. (Pubitemid 351458450)
22. Bryant RA, Felmingham K, Kemp A, Das P, Hughes G, Peduto A, Williams L. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med. 2008;38(4):555-561. (Pubitemid 351354888)
23. Sabatinelli D, Fortune EE, Li Q, Siddiqui A, Krafft C, Oliver WT, Beck S, Jeffries J. Emotional perception: meta-analyses of face and natural scene processing. Neuroimage. 2011;54(3):2524-2533.
24. Stein MB, Goldin PR, Sareen J, Zorrilla LT, Brown GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry. 2002;59(11):1027-1034.
25. Straube T, Mentzel HJ,Miltner WH. Common and distinct brain activation to threat and safety signals in social phobia. Neuropsychobiology. 2005;52(3):163-168. (Pubitemid 41318196)
26. Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164(10):1476-1488. (Pubitemid 350069724)
27. Fusar-Poli P, Placentino A, Carletti F, Landi P, Allen P, Surguladze S, Benedetti F, Abbamonte M, Gasparotti R, Barale F, Perez J, McGuire P, Politi P. Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci. 2009;34(6):418-432.
28. Goldin PR, Manber T, Hakimi S, Canli T, Gross JJ. Neural bases of social anxiety disorder: emotional reactivity and cognitive regulation during social and physical threat. Arch Gen Psychiatry. 2009;66(2):170-180.
29. Hofmann SG, Otto MW. Cognitive Behavioral Therapy for Social Anxiety Disorder: Evidence-Based and Disorder-Specific Treatment Techniques. New York, NY: Routledge; 2008.
30. Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med. 1999;29(1):199-212. (Pubitemid 29034537)
31. Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006;63(3):298-304. (Pubitemid 43345354)
32. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/PSY SCREEN). New York: Biometrics Research, New York State Psychiatric Institute; 1997.
33. DiNardo PA, Brown TA, Barlow DH. Anxiety Disorders Interview Schedule for DSMIV: Lifetime Version (ADIS-IV-L). San Antonio, TX: Psychological Corp; 1994.
34. Tottenham N, Tanaka JW, Leon AC, McCarry T, Nurse M, Hare TA, Marcus DJ, Westerlund A, Casey BJ, Nelson C. The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Res. 2009;168(3):242-249.
35. Lang PJ, Bradley MM, Cuthbert BN. International Affective Picture System (IAPS): Technical Manual And Affective Ratings. Gainesville, FL: NIMH Center for the Study of Emotion and Attention; 1997.
36. Thesen S, Heid O, Mueller E, Schad LR. Prospective acquisition correction for head motion with image-based tracking for real-time fMRI. Magn Reson Med. 2000;44(3):457-465.
37. Gorgolewski K, Burns CD, Madison C, Clark D, Halchenko YO, Waskom ML, Ghosh SS. Nipype: a flexible, lightweight and extensible neuroimaging data processing framework in python. Front Neuroinform. 2011;5:13.
38. Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26(3):839-851. (Pubitemid 40825026)
39. Chumbley JR, Friston KJ. False discovery rate revisited: FDR and topological inference using gaussian random fields. Neuroimage. 2009;44(1):62-70.
40. Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, Blondel M, Prettenhofer P, Weiss R, Dubourg V, Vanderplas J, Passos A, Cournapeau D, Brucher M, Perrot M, Duchesnay E. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12(Oct):2825-2830.
41. Dwass M. Modified randomization tests for nonparametric hypotheses. Ann Math Stat. 1957;28(1):181-187. doi:10.1214/aoms/1177707045.
42. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19(3):1233-1239. (Pubitemid 36918259)
43. Kriegeskorte N, Simmons WK, Bellgowan PS, Baker CI. Circular analysis in systems neuroscience: the dangers of double dipping. Nat Neurosci. 2009;12(5):535-540.
44. Scholing A, Emmelkamp PM. Prediction of treatment outcome in social phobia: a cross-validation. Behav Res Ther. 1999;37(7):659-670. (Pubitemid 29241786)
45. Phan KL, Fitzgerald DA, Nathan PJ, Tancer ME. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry. 2006;59(5):424-429. (Pubitemid 43289221)
46. Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, Stout JC, Nathan PJ. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology. 2010;35(12):2403-2413.
47. Pessoa L, Adolphs R. Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance. Nat Rev Neurosci. 2010;11(11):773-783.
48. Dima D, Stephan KE, Roiser JP, Friston KJ, Frangou S. Effective connectivity during processing of facial affect: evidence for multiple parallel pathways. J Neurosci. 2011;31(40):14378-14385.
49. Brühl AB, Rufer M, Delsignore A, Kaffenberger T, Jäncke L, Herwig U. Neural correlates of altered general emotion processing in social anxiety disorder. Brain Res. 2011;1378:72-83.
50. Evans KC, Wright CI, Wedig MM, Gold AL, Pollack MH, Rauch SL. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety. 2008;25(6):496-505. (Pubitemid 351898390)
51. Liao W, Qiu C, Gentili C, Walter M, Pan Z, Ding J, Zhang W, Gong Q, Chen H. Altered effective connectivity network of the amygdala in social anxiety disorder: a resting-state FMRI study. PLoS One. 2010;5(12):e15238.
52. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Långström B, Fredrikson M. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry. 2002;59(5):425-433. (Pubitemid 34477677)
53. Goldin PR, Gross JJ. Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion. 2010;10(1):83-91.
54. Kilts CD, Kelsey JE, Knight B, Ely TD, Bowman FD, Gross RE, Selvig A, Gordon A, Newport DJ, Nemeroff CB. The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology. 2006;31(10):2243-2253. (Pubitemid 44413202)
55. Wager TD, Davidson ML, Hughes BL, Lindquist MA, Ochsner KN. Prefrontalsubcortical pathways mediating successful emotion regulation. Neuron. 2008;59(6):1037-1050.
56. Fu CH, Williams SC, Brammer MJ, Suckling J, Kim J, Cleare AJ, Walsh ND, Mitterschiffthaler MT, Andrew CM, Pich EM, Bullmore ET. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry. 2007;164(4):599-607. (Pubitemid 46650191)
57. Mueller EM, Hofmann SG, Santesso DL, Meuret AE, Bitran S, Pizzagalli DA. Electrophysiological evidence of attentional biases in social anxiety disorder. Psychol Med. 2009;39(7):1141-1152.
58. Mansell W, Clark DM, Ehlers A, Chen YP. Social anxiety and attention away from emotional faces. Cogn Emotion . 1999;13(6):673-690. doi:10.1080/ 026999399379032.
59. Amir N, Beard C, Taylor CT, Klumpp H, Elias J, Burns M, Chen X. Attention training in individuals with generalized social phobia: a randomized controlled trial. J Consult Clin Psychol. 2009;77(5):961-973.
60. Monk CS, Nelson EE, Woldehawariat G, Montgomery LA, Zarahn E, McClure EB, Guyer AE, Leibenluft E, Charney DS, Ernst M, Pine DS. Experience-dependent plasticity for attention to threat: behavioral and neurophysiological evidence in humans. Biol Psychiatry. 2004;56(8):607-610. (Pubitemid 39336409)
61. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S, Kohli MA, Hennings JM, Horstmann S, Kloiber S, Menke A, Bondy B, Rupprecht R, Domschke K, Baune BT, Arolt V, Rush AJ, Holsboer F, Müller-Myhsok B. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry. 2009;66(9):966-975.
62. Kemp AH, Gordon E, Rush AJ, Williams LM. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr. 2008;13(12):1066-1086, quiz 1087-1088.
63. Siegle GJ, Steinhauer SR, Friedman ES, Thompson WS, Thase ME. Remission prognosis for cognitive therapy for recurrent depression using the pupil: utility and neural correlates. Biol Psychiatry. 2011;69(8):726-733.